secwatch.observer — SEC 8-K summary
======================================

Issuer:     RITE AID CORP (—)
CIK:        0000084129
Form:       8-K
Filed at:   2023-12-27T23:59:59+00:00
Accession:  0001104659-23-129388
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 1.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rite Aid gets court approval for $604M seller financing to MedImpact for Elixir sale; no other bids.
--------------------------------------------------------------------------------

- Bankruptcy Court approved seller financing of up to $604M to MedImpact for Elixir pharmacy benefit manager sale.
- MedImpact named successful bidder for Elixir Assets after no other qualified bids by Dec 18 deadline.
- DIP ABL facility ($3.25B) and DIP term loan ($200M) received final court approval on Dec 22, 2023.
- Company warns equity holders could face significant or complete loss; trading in securities highly speculative.
- Hearing to approve Elixir sale set for Jan 9, 2024; closing subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/84129/000110465923129388/0001104659-23-129388-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/84129/000110465923129388/tm2333722d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-129388

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer